carmoterol has been researched along with Asthma, Bronchial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cazzola, M; Matera, MG | 1 |
De Backer, JW; De Backer, W; Devolder, A; Germonpré, P; Parizel, PM; Verhulst, SL; Vos, WG; Wuyts, FL | 1 |
1 review(s) available for carmoterol and Asthma, Bronchial
Article | Year |
---|---|
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Amphetamines; Animals; Asthma; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Humans; Hydroxyquinolines; Indans; Pulmonary Disease, Chronic Obstructive; Quinolones | 2007 |
1 trial(s) available for carmoterol and Asthma, Bronchial
Article | Year |
---|---|
Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation.
Topics: Adrenergic beta-Agonists; Adult; Airway Resistance; Amphetamines; Asthma; Bronchi; Bronchodilator Agents; Computational Biology; Computer Simulation; Female; Forced Expiratory Volume; Humans; Hydroxyquinolines; Male; Middle Aged; Models, Biological; Quinolones; Respiratory Function Tests; Rheology; Spirometry; Tomography, X-Ray Computed; Total Lung Capacity; Vital Capacity | 2008 |